Diagnostic performance of an automatic blood pressure measurement device, Microlife WatchBP Home A, for atrial fibrillation screening in a real-world primary care setting.

ABSTRACT:

Objective

To evaluate the diagnostic performance of a UK National Institute for Health and Care Excellence-recommended automatic oscillometric blood pressure (BP) measurement device incorporated with an atrial fibrillation (AF) detection algorithm (Microlife WatchBP Home A) for real-world AF screening in a primary healthcare setting.

Setting

Primary healthcare setting in Hong Kong.

Interventions

This was a prospective AF screening study carried out between 1 September 2014 and 14 January 2015. The Microlife device was evaluated for AF detection and compared with a reference standard of lead-I ECG.

Primary outcome measures

Diagnostic performance of Microlife for AF detection.

Results

5969 patients (mean age: 67.2±11.0 years; 53.9% female) were recruited.

SUBMITTER: Chan PH 

PROVIDER: S-EPMC5577883 | biostudies-literature | 2017 Jun

REPOSITORIES: biostudies-literature